April 2016 - Evolution Biotechnologies
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Evolution Biotechnologies (www.evolutionbiotech.com), the UK-based company established to expand the use of biological control into medically important areas, today announced the appointment of Dr. Victor Brugman as senior scientist on its dust mite control project. Dr. Brugman will be working with the ARCTEC unit at the London School of Hygiene and Tropical Medicine in London in the early stages of the work, and will be moving to the company’s central facility at Colworth Science Park later in the year. Dr. David Harper, Chief Officer of Evolution, said “This is an important step for the company, I would like to welcome Dr....